# Nurx The compounder that publishes everything: concentrations, container volumes, prices, billing cadence and an explicit statement that its compounded products were never assessed by the FDA — all on the page you buy from. It is the disclosure standard the rest of this register has been asked for and refused. - **Canonical:** https://www.30plusskin.care/brands/nurx - **Site:** 30+/SKIN — Skincare, published as a spec sheet. - **Issue:** ISSUE NO. 13 / REV. 2026.10 - **Standing terms:** INDEPENDENT · AFFILIATE-FUNDED · NOT MEDICAL ADVICE --- ## The operation - **Category:** TELEHEALTH · GENERIC PRESCRIPTIONS AND COMPOUNDED FORMULAS - **Model:** Online consultation, licensed provider review, pharmacy dispensing. Both single-agent generics at approved strengths and in-house compounded formulas. Medication shipped and billed every one, two or three months. - **Products assessed:** 1 - **Mean score:** 74/100 - **Mean disclosure score:** 88/100 - **Pricing:** See each offer and billing period in the product records - **Brand site:** https://www.nurx.com - **TRADING NAME:** NURX - **PARENT:** THIRTY MADISON, INC. - **MODEL:** TELEHEALTH → GENERIC AND COMPOUNDED DISPENSING - **RANGE ASSESSED:** 1 PRODUCT FAMILY - **FDA STATUS OF COMPOUNDS:** STATED ON THE PAGE — NOT APPROVED - **INSURANCE:** ACCEPTED FOR ACNE AND ROSACEA ONLY - **FORMULA DISCLOSURE:** CONCENTRATIONS AND VOLUMES PUBLISHED; NO EXCIPIENT LISTS ## Verdict One product family assessed so far, so this is a note rather than a pattern analysis, but it is the most consequential note in the brand register. Nurx does, unprompted and before purchase, what nine other telehealth companies here do not: it prints the concentration of every active, the volume of every container, the price, the billing cycle, and — on every compounded formula — the sentence 'It has not been FDA-approved or evaluated for safety, efficacy, or quality.' It goes further than that. The spironolactone listing states that the drug is not FDA approved for acne and that the company in no way endorses that use, which is a piece of regulatory candour we have not seen elsewhere in this category. Insurance coverage is stated by indication, including which indications are not covered and why. Full prescribing information is linked for every single-agent product. The single-agent generics alongside the compounds are the quiet argument. Tretinoin cream at three approved strengths in a 45 g tube, adapalene 0.3%, hydroquinone 4% in a 1 oz tube. For most people arriving wanting 'prescription skincare', one of those is the answer, and Nurx is the only service here that lets you see the approved option next to the compounded one on the same screen. The failure is a specific one. The Dark Spots Formula puts five actives in a 26 ml bottle including hydrocortisone 1% and kojic acid 6%, and states no duration, no review point and no stop date. The approved product built on the same three-drug logic is licensed short-term only, because of exactly that corticosteroid. Everything else on the page is exemplary, which makes the omission conspicuous rather than characteristic. ## What the reviewed offering tells us ### 01 — The concentration is on the page you buy from Azelaic acid 10%, niacinamide 4%, tretinoin 0.025/0.05/0.1%, in a 26 ml bottle, for $90 — visible without a consultation, without an account and without a help-centre search. This is the single thing this register has asked every telehealth company for, and Nurx is the first to simply do it. ### 02 — The container size is published too, so the maths works 45 g tube, 26 ml bottle, 1 oz tube, 86 ml bottle. Cost per application is computable across the whole catalogue. Not one Musely product, not one Alloy product and few of Dermatica's allow the same calculation. ### 03 — It states its own regulatory status Every compounded product carries an explicit statement that it is not FDA approved or evaluated. Obagi, a manufactured product whose FDA listing carries the same disclaimer, does not print it. Nurx does, on a product it makes itself and sells directly. ### 04 — And then a corticosteroid with no end date The Dark Spots Formula contains hydrocortisone 1% alongside hydroquinone 4% and tretinoin 0.05%, sold in three-month billing blocks with no stated duration. A three-month billing block is not a three-month course. The approved equivalent says to stop when control is achieved; this page says nothing. ### 05 — One active in the range has no business being there Kojic acid at 6% has no approved dermatological indication, a thin trial base and a recognised contact sensitisation risk, in a formula that already contains the best-evidenced depigmenting agent available. Publishing the number is good. The number is still unsupported. ## Credit where it is due - Every active concentration printed on the product listing, before purchase. - Every container volume published — 45 g, 26 ml, 1 oz, 86 ml. - An explicit 'not FDA-approved or evaluated for safety, efficacy, or quality' statement on every compounded product. - The spironolactone listing states it is not FDA approved for acne and that the company does not endorse that use. - Single-agent generics at approved strengths offered alongside the compounds. - Tretinoin offered at three strengths, all inside the trial range. - Hydroquinone offered at 4%, the conventional prescription concentration. - Insurance coverage stated by indication, including the indications it does not cover. - Named side effects and links to full prescribing information on each listing. - Billing cadence stated plainly: shipped and billed every one, two or three months. ## Disclosure matrix | Product | CONC. ON PAGE | CONC. FINDABLE | CONTRA-INDICATIONS | SIZE | SIDE EFFECTS | | --- | --- | --- | --- | --- | --- | | Nurx Prescription Skincare | yes | yes | partial | yes | yes | ## Reviews | No. | Product | Stance | Score | Price | Document | | --- | --- | --- | --- | --- | --- | | R-43 | Prescription Skincare — Tretinoin, ReviveRx, Dark Spots Formula | CONDITIONAL | 74/100 | $30 | /reviews/nurx-prescription-skincare-review | ## Related records - [L-15 Online prescription skincare companies: compare the route to care](/ledger/online-prescription-skincare-companies) - [L-13 What prescription skincare really costs: count the visit and the refill](/ledger/prescription-skincare-total-cost) - [PROFILE Miiskin](/brands/miiskin) --- ## PROMOTIONAL SPOTLIGHT: Explore CoreAge Rx skincare More options for your skin. A patient community to connect with along the way. **Five skincare options to explore** — Browse CoreAge Rx's prescription skincare range for concerns including fine lines, dark spots, blemishes and more. **Connect with other patients** — Explore the CoreAge Rx patient community for shared experiences, conversations and support beyond your daily routine. [CHECK OUT COREAGE RX SKINCARE](https://try.coreagerx.com/skincare?utm_source=30plusskin.care&utm_medium=affiliate&utm_campaign=skincare_reviews&utm_content=reading_footer) [EXPLORE THE PATIENT COMMUNITY](https://community.coreagerx.com/) [Read our CoreAge Rx reviews](/reviews/coreage-rx-skincare-review) Prescription options require a clinician's assessment. Compounded medications are not FDA-approved. Community discussions do not replace medical advice. [Product range](https://help.coreagerx.com/medication/coreage-rx-prescription-skincare) · [Community information](https://www.coreagerx.com/contact-us/) [About promotional placements](/disclosure) --- ## Elsewhere in the register - [Review register](/reviews) - [Active monographs](/actives) - [Brand register](/brands) - [Evidence register](/evidence) - [The ledger](/ledger) - [How we test](/how-we-test) - [Agent guide](/llms.txt) - [Sitemap](/sitemap.xml) _SOURCE-BASED ASSESSMENTS. PUBLISHER PREFERENCES ARE IDENTIFIED SEPARATELY._